Screener
Indivior Pharmaceuticals, Inc. INDV Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current liabilities | 779 | 914 |
| Long-term debt, less current portion | 486 | 290 |
| Accrued litigation settlement expenses, noncurrent | 41 | 52 |
| Operating lease liabilities, noncurrent | 14 | 22 |
| Other noncurrent liabilities | 21 | 21 |
| Total liabilities | $1,341 | $1,300 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' deficit |
Item 1. Unaudited Condensed Financial Statements.
FAQ
- What is Indivior Pharmaceuticals, Inc.'s operating lease liabilities?
- Indivior Pharmaceuticals, Inc. (INDV) reported operating lease liabilities of $14M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s operating lease liabilities changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s operating lease liabilities decreased by 53.3% year-over-year, from $30M to $14M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s operating lease liabilities?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc.'s operating lease liabilities has grown at a -19.6% compound annual growth rate (CAGR), from $34M to $22M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Indivior Pharmaceuticals, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude